PMC:7212965 / 65058-65603 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T150","span":{"begin":193,"end":199},"obj":"Body_part"},{"id":"T151","span":{"begin":256,"end":261},"obj":"Body_part"}],"attributes":[{"id":"A150","pred":"fma_id","subj":"T150","obj":"http://purl.org/sig/ont/fma/fma228738"},{"id":"A151","pred":"fma_id","subj":"T151","obj":"http://purl.org/sig/ont/fma/fma7197"}],"text":" Liu, 202052Central Hospital of Wuhan (Wuhan)Dates: 1/2/2020-2/1/2020Last follow-up: NR n = 109Survival: 28.4% died, NR otherwiseInclusion: Inpatient with COVID-19 confirmed based on RT-PCR on throat swabAge: M 62.5 y (IQR, 47.25–65 y)Sex: 33.3% femalesGI/liver comorbidities: NRDisease severity: NR Diarrhea: 11% (12)Present on admission6/12 with ARDS and 6/12 with no ARDSNausea, vomiting and abdominal pain: NR AST:M 30 (IQR, 21–40)No ARDS 29 (19–38); ARDS 31 (25–44)ALT:M 23 (IQR, 15–36)No ARDS 23 (14–41); ARDS 24 (16–31)Total bilirubin: NR"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T118","span":{"begin":193,"end":199},"obj":"Body_part"},{"id":"T119","span":{"begin":256,"end":261},"obj":"Body_part"}],"attributes":[{"id":"A118","pred":"uberon_id","subj":"T118","obj":"http://purl.obolibrary.org/obo/UBERON_0000341"},{"id":"A119","pred":"uberon_id","subj":"T119","obj":"http://purl.obolibrary.org/obo/UBERON_0002107"}],"text":" Liu, 202052Central Hospital of Wuhan (Wuhan)Dates: 1/2/2020-2/1/2020Last follow-up: NR n = 109Survival: 28.4% died, NR otherwiseInclusion: Inpatient with COVID-19 confirmed based on RT-PCR on throat swabAge: M 62.5 y (IQR, 47.25–65 y)Sex: 33.3% femalesGI/liver comorbidities: NRDisease severity: NR Diarrhea: 11% (12)Present on admission6/12 with ARDS and 6/12 with no ARDSNausea, vomiting and abdominal pain: NR AST:M 30 (IQR, 21–40)No ARDS 29 (19–38); ARDS 31 (25–44)ALT:M 23 (IQR, 15–36)No ARDS 23 (14–41); ARDS 24 (16–31)Total bilirubin: NR"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T322","span":{"begin":155,"end":163},"obj":"Disease"},{"id":"T323","span":{"begin":300,"end":308},"obj":"Disease"},{"id":"T324","span":{"begin":348,"end":352},"obj":"Disease"},{"id":"T325","span":{"begin":438,"end":442},"obj":"Disease"},{"id":"T326","span":{"begin":455,"end":459},"obj":"Disease"},{"id":"T327","span":{"begin":494,"end":498},"obj":"Disease"},{"id":"T328","span":{"begin":511,"end":515},"obj":"Disease"}],"attributes":[{"id":"A322","pred":"mondo_id","subj":"T322","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A323","pred":"mondo_id","subj":"T323","obj":"http://purl.obolibrary.org/obo/MONDO_0001673"},{"id":"A324","pred":"mondo_id","subj":"T324","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A325","pred":"mondo_id","subj":"T325","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A326","pred":"mondo_id","subj":"T326","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A327","pred":"mondo_id","subj":"T327","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A328","pred":"mondo_id","subj":"T328","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"}],"text":" Liu, 202052Central Hospital of Wuhan (Wuhan)Dates: 1/2/2020-2/1/2020Last follow-up: NR n = 109Survival: 28.4% died, NR otherwiseInclusion: Inpatient with COVID-19 confirmed based on RT-PCR on throat swabAge: M 62.5 y (IQR, 47.25–65 y)Sex: 33.3% femalesGI/liver comorbidities: NRDisease severity: NR Diarrhea: 11% (12)Present on admission6/12 with ARDS and 6/12 with no ARDSNausea, vomiting and abdominal pain: NR AST:M 30 (IQR, 21–40)No ARDS 29 (19–38); ARDS 31 (25–44)ALT:M 23 (IQR, 15–36)No ARDS 23 (14–41); ARDS 24 (16–31)Total bilirubin: NR"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T463","span":{"begin":256,"end":261},"obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"T464","span":{"begin":256,"end":261},"obj":"http://www.ebi.ac.uk/efo/EFO_0000887"},{"id":"T465","span":{"begin":310,"end":312},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T466","span":{"begin":357,"end":361},"obj":"http://purl.obolibrary.org/obo/CLO_0001442"},{"id":"T467","span":{"begin":488,"end":490},"obj":"http://purl.obolibrary.org/obo/CLO_0001313"},{"id":"T468","span":{"begin":506,"end":508},"obj":"http://purl.obolibrary.org/obo/CLO_0053794"}],"text":" Liu, 202052Central Hospital of Wuhan (Wuhan)Dates: 1/2/2020-2/1/2020Last follow-up: NR n = 109Survival: 28.4% died, NR otherwiseInclusion: Inpatient with COVID-19 confirmed based on RT-PCR on throat swabAge: M 62.5 y (IQR, 47.25–65 y)Sex: 33.3% femalesGI/liver comorbidities: NRDisease severity: NR Diarrhea: 11% (12)Present on admission6/12 with ARDS and 6/12 with no ARDSNausea, vomiting and abdominal pain: NR AST:M 30 (IQR, 21–40)No ARDS 29 (19–38); ARDS 31 (25–44)ALT:M 23 (IQR, 15–36)No ARDS 23 (14–41); ARDS 24 (16–31)Total bilirubin: NR"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T94781","span":{"begin":85,"end":87},"obj":"Chemical"},{"id":"T76721","span":{"begin":117,"end":119},"obj":"Chemical"},{"id":"T60387","span":{"begin":297,"end":299},"obj":"Chemical"},{"id":"T56717","span":{"begin":411,"end":413},"obj":"Chemical"},{"id":"T96798","span":{"begin":532,"end":541},"obj":"Chemical"},{"id":"T69892","span":{"begin":543,"end":545},"obj":"Chemical"}],"attributes":[{"id":"A55805","pred":"chebi_id","subj":"T94781","obj":"http://purl.obolibrary.org/obo/CHEBI_145751"},{"id":"A4938","pred":"chebi_id","subj":"T76721","obj":"http://purl.obolibrary.org/obo/CHEBI_145751"},{"id":"A67003","pred":"chebi_id","subj":"T60387","obj":"http://purl.obolibrary.org/obo/CHEBI_145751"},{"id":"A4234","pred":"chebi_id","subj":"T56717","obj":"http://purl.obolibrary.org/obo/CHEBI_145751"},{"id":"A31421","pred":"chebi_id","subj":"T96798","obj":"http://purl.obolibrary.org/obo/CHEBI_16990"},{"id":"A68899","pred":"chebi_id","subj":"T69892","obj":"http://purl.obolibrary.org/obo/CHEBI_145751"}],"text":" Liu, 202052Central Hospital of Wuhan (Wuhan)Dates: 1/2/2020-2/1/2020Last follow-up: NR n = 109Survival: 28.4% died, NR otherwiseInclusion: Inpatient with COVID-19 confirmed based on RT-PCR on throat swabAge: M 62.5 y (IQR, 47.25–65 y)Sex: 33.3% femalesGI/liver comorbidities: NRDisease severity: NR Diarrhea: 11% (12)Present on admission6/12 with ARDS and 6/12 with no ARDSNausea, vomiting and abdominal pain: NR AST:M 30 (IQR, 21–40)No ARDS 29 (19–38); ARDS 31 (25–44)ALT:M 23 (IQR, 15–36)No ARDS 23 (14–41); ARDS 24 (16–31)Total bilirubin: NR"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T294","span":{"begin":300,"end":308},"obj":"Phenotype"},{"id":"T295","span":{"begin":382,"end":390},"obj":"Phenotype"},{"id":"T296","span":{"begin":395,"end":409},"obj":"Phenotype"}],"attributes":[{"id":"A294","pred":"hp_id","subj":"T294","obj":"http://purl.obolibrary.org/obo/HP_0002014"},{"id":"A295","pred":"hp_id","subj":"T295","obj":"http://purl.obolibrary.org/obo/HP_0002013"},{"id":"A296","pred":"hp_id","subj":"T296","obj":"http://purl.obolibrary.org/obo/HP_0002027"}],"text":" Liu, 202052Central Hospital of Wuhan (Wuhan)Dates: 1/2/2020-2/1/2020Last follow-up: NR n = 109Survival: 28.4% died, NR otherwiseInclusion: Inpatient with COVID-19 confirmed based on RT-PCR on throat swabAge: M 62.5 y (IQR, 47.25–65 y)Sex: 33.3% femalesGI/liver comorbidities: NRDisease severity: NR Diarrhea: 11% (12)Present on admission6/12 with ARDS and 6/12 with no ARDSNausea, vomiting and abdominal pain: NR AST:M 30 (IQR, 21–40)No ARDS 29 (19–38); ARDS 31 (25–44)ALT:M 23 (IQR, 15–36)No ARDS 23 (14–41); ARDS 24 (16–31)Total bilirubin: NR"}

{"project":"LitCovid-sentences","denotations":[{"id":"T508","span":{"begin":0,"end":51},"obj":"Sentence"},{"id":"T509","span":{"begin":52,"end":104},"obj":"Sentence"},{"id":"T510","span":{"begin":105,"end":139},"obj":"Sentence"},{"id":"T511","span":{"begin":140,"end":208},"obj":"Sentence"},{"id":"T512","span":{"begin":209,"end":239},"obj":"Sentence"},{"id":"T513","span":{"begin":240,"end":309},"obj":"Sentence"},{"id":"T514","span":{"begin":310,"end":545},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" Liu, 202052Central Hospital of Wuhan (Wuhan)Dates: 1/2/2020-2/1/2020Last follow-up: NR n = 109Survival: 28.4% died, NR otherwiseInclusion: Inpatient with COVID-19 confirmed based on RT-PCR on throat swabAge: M 62.5 y (IQR, 47.25–65 y)Sex: 33.3% femalesGI/liver comorbidities: NRDisease severity: NR Diarrhea: 11% (12)Present on admission6/12 with ARDS and 6/12 with no ARDSNausea, vomiting and abdominal pain: NR AST:M 30 (IQR, 21–40)No ARDS 29 (19–38); ARDS 31 (25–44)ALT:M 23 (IQR, 15–36)No ARDS 23 (14–41); ARDS 24 (16–31)Total bilirubin: NR"}

{"project":"LitCovid-PubTator","denotations":[{"id":"2384","span":{"begin":155,"end":163},"obj":"Disease"},{"id":"2385","span":{"begin":300,"end":308},"obj":"Disease"},{"id":"2386","span":{"begin":348,"end":352},"obj":"Disease"},{"id":"2387","span":{"begin":370,"end":380},"obj":"Disease"},{"id":"2388","span":{"begin":382,"end":390},"obj":"Disease"},{"id":"2389","span":{"begin":395,"end":409},"obj":"Disease"},{"id":"2390","span":{"begin":438,"end":442},"obj":"Disease"},{"id":"2391","span":{"begin":455,"end":459},"obj":"Disease"},{"id":"2392","span":{"begin":494,"end":498},"obj":"Disease"},{"id":"2393","span":{"begin":511,"end":515},"obj":"Disease"}],"attributes":[{"id":"A2384","pred":"tao:has_database_id","subj":"2384","obj":"MESH:C000657245"},{"id":"A2385","pred":"tao:has_database_id","subj":"2385","obj":"MESH:D003967"},{"id":"A2386","pred":"tao:has_database_id","subj":"2386","obj":"MESH:D012128"},{"id":"A2388","pred":"tao:has_database_id","subj":"2388","obj":"MESH:D014839"},{"id":"A2389","pred":"tao:has_database_id","subj":"2389","obj":"MESH:D015746"},{"id":"A2390","pred":"tao:has_database_id","subj":"2390","obj":"MESH:D012128"},{"id":"A2391","pred":"tao:has_database_id","subj":"2391","obj":"MESH:D012128"},{"id":"A2392","pred":"tao:has_database_id","subj":"2392","obj":"MESH:D012128"},{"id":"A2393","pred":"tao:has_database_id","subj":"2393","obj":"MESH:D012128"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" Liu, 202052Central Hospital of Wuhan (Wuhan)Dates: 1/2/2020-2/1/2020Last follow-up: NR n = 109Survival: 28.4% died, NR otherwiseInclusion: Inpatient with COVID-19 confirmed based on RT-PCR on throat swabAge: M 62.5 y (IQR, 47.25–65 y)Sex: 33.3% femalesGI/liver comorbidities: NRDisease severity: NR Diarrhea: 11% (12)Present on admission6/12 with ARDS and 6/12 with no ARDSNausea, vomiting and abdominal pain: NR AST:M 30 (IQR, 21–40)No ARDS 29 (19–38); ARDS 31 (25–44)ALT:M 23 (IQR, 15–36)No ARDS 23 (14–41); ARDS 24 (16–31)Total bilirubin: NR"}